Validation of an in-house developed therapeutic dosimetric software tool for the treatment of 177Lutetium-DOTATATE peptide receptor radionuclide therapy

Category Primary study
JournalHealth and Technology
Year 2024
This article has no abstract
Epistemonikos ID: 83595d9a9c42496e3eb53af5f30199970d775ac8
First added on: Jun 14, 2024